Organization Overview
Historical Acquisition Tree
Key: Smith, Kline & French (9) Acquired (1)
triflupromazine (vesprin) (1957 NDA)
Key: Smith, Kline & French (0) Acquired (64)
adapalene (differin) (4 trials)
aflibercept (zaltrap) (3 trials)
alcaftadine (Lastacaft) (6 trials)
benzoyl peroxide (clearasil) (2 trials)
bevacizumab (avastin) (8 trials)
bimatoprost (lumigan) (71 trials)
brimonidine (alphagan) (35 trials)
brinzolamide (azopt) (2 trials)
carboxymethyl cellulose (3 trials)
ceftaroline fosamil (teflaro) (1 trial)
cyclosporine (sandimmune) (17 trials)
dalbavancin (dalvance) (14 trials)
deoxycholic acid (kybella) (5 trials)
dorzolamide (trusopt) (4 trials)
duloxetine (Cymbalta) (1 trial)
eluxadoline (viberzi) (5 trials)
gatifloxacin (Zymar) (7 trials)
ketorolac (acuvail) (9 trials)
levomilnacipran (fetzima) (4 trials)
linaclotide (linzess) (10 trials)
metronidazole (flagyl) (2 trials)
minocycline (minocin) (1 trial)
moxifloxacin (avelox) (4 trials)
naphazoline (visine) (1 trial)
nepafenac (nevanac) (4 trials)
olopatadine (patanol) (4 trials)
omega-3 fatty acids (Omacor) (1 trial)
onabotulinumtoxinA (Botox) (37 trials)
oxybutynin (ditropan) (2 trials)
oxymetazoline (ocuclear) (4 trials)
pheniramine (Tripoton) (1 trial)
ranibizumab (lucentis) (18 trials)
rimabotulinumtoxinB (Myobloc) (129 trials)
tafluprost (zioptan) (1 trial)
tazarotene (tazorac) (5 trials)
testosterone (delatestryl) (2 trials)
timolol (blocadren) (35 trials)
tizanidine (zanaflex) (1 trial)
topiramate (topamax) (2 trials)
travoprost (travatan) (6 trials)
triamcinolone (kenalog) (7 trials)
Key: Smith, Kline & French (0) Acquired (34)
budesonide (rhinocort) (6 trials)
cariprazine (vraylar) (12 trials)
dihydroergotamine (D.H.E. 45) (5 trials)
escitalopram (lexapro) (1 trial)
Key: Smith, Kline & French (0) Acquired (30)
albuterol (proventil) (2 trials)
altretamine (hexalen) (3 trials)
beclomethasone (vanceril) (1 trial)
ceftazidime (fortaz) (3 trials)
Key: Smith, Kline & French (0) Acquired (4)